Thar Pharmaceuticals, Inc clinical trials

Acquired by Grünenthal GmbH, 2016 · source ↗

The registry lists 1 studies whose lead sponsor is Thar Pharmaceuticals, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 26, 2015.

Before and after it joined Grünenthal GmbH

First submitted before Thar Pharmaceuticals, Inc became part of Grünenthal GmbH: 1
First submitted after Thar Pharmaceuticals, Inc became part of Grünenthal GmbH: 0
Unclear, or no submission date: 0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Status

Completed: 1

Phase

Phase 1: 1

Where

United States: 1

Registry sponsor names on this page

Thar Pharmaceuticals, Inc1 study

Something wrong with this grouping? Tell us on the Grünenthal GmbH page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Grünenthal GmbH studies →

Open Label Dose Escalation Phase I Study to Investigate the Safety and Pharmacokinetics of T121E01F and T121E02F in Healthy Postmenopausal WomenCompletedNCT01721993Phase 1
Sponsor listed in the registry: Thar Pharmaceuticals, Inc · First submitted before Thar Pharmaceuticals, Inc became part of Grünenthal GmbH